德克萨米他对糖尿病酸性症并发症的临床疗效与急性胰腺炎:一项随机对照研究
1Department of Emergency Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China.
Medicine
|October 13, 2023
概括
德克萨米他有效治疗糖尿病酸性 (DKA) 与急性胰腺炎 (AP). 与安慰剂相比,这种治疗改善了患者的症状和实验室结果,同时减少了不良事件.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
背景情况:
- 糖尿病酸症 (DKA) 和急性胰腺炎 (AP) 是严重的并发症.
- 对同时发生的DKA和AP有效的治疗策略至关重要.
研究的目的:
- 评估德克萨米他在治疗DAK复杂的AP患者中的临床疗效.
- 在这个患者群体中为德克萨米他治疗提供临床基础.
主要方法:
- 一项随机对照试验,涉及106名患有DKA和AP的患者.
- 患者被分为一个德克萨梅他治疗组 (n=53) 和一个安慰剂组 (n=53).
- 实验室指数,临床症状和治疗前后不良事件的比较.
主要成果:
- 德克萨米他治疗显著改善了血糖控制,电解质平衡和胰腺炎标志物 (血清氨酶,甘油三).
- 接受德克萨米他治疗的患者表现出明显的改善,包括腹痛,恶心,吐和意识改变等症状.
- 与安慰剂组 (58.5%) 相比,德克萨米他组 (17.0%) 的不良事件发生率明显较低.
结论:
- 德克萨米他在治疗与急性胰腺炎复杂的糖尿病酸性症方面表现出显著的临床疗效.
- 这种治疗提供了一个有前途的治疗选择,具有更好的结果和更好的安全性.
相关概念视频
Acute Pancreatitis II: Clinical Manifestations and Management
132
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
132
Acute Pancreatitis I: Introduction
381
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
381
Chronic Pancreatitis II: Collaborative Care
97
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
97
Hypoglycemia and Glucagon
274
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
274
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Dipeptidyl Peptidase 4 Inhibitors
192
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
192


